載入...
lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141
BACKGROUND: 5-Fluorouracil (5-FU) has been widely applied to treat various types of cancers, including hepatocellular carcinoma (HCC). However, primary or acquired 5-FU resistance prevents the clinical application of this drug in cancer therapy. Herein, our study is the first to demonstrate that low...
Na minha lista:
| 發表在: | Cell Commun Signal |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6098660/ https://ncbi.nlm.nih.gov/pubmed/30119680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-018-0260-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|